Anti-Parkinson's Disease Activity of Sanghuangprous vaninii Extracts in the MPTP-Induced Zebrafish Model

被引:15
|
作者
Li, Xuezhen [1 ,2 ,3 ]
Gao, Daili [2 ]
Paudel, Yam Nath [4 ]
Li, Xia [5 ]
Zheng, Mingzhu [3 ]
Liu, Guangpeng [1 ]
Ma, Yanrui [1 ]
Chu, Le [1 ]
He, Fatao [1 ]
Jin, Meng [2 ]
机构
[1] Jinan Fruit Res Inst, All China Federat Supply & Mkt Cooperat, Jinan 250103, Shandong, Peoples R China
[2] Qilu Univ Technol, Biol Inst, Shandong Acad Sci, Jinan 250103, Shandong, Peoples R China
[3] Jilin Agr Univ, Changchun 130118, Jilin, Peoples R China
[4] Monash Univ Malaysia, Jeffrey Cheah Sch Med & Hlth Sci, Neuropharmacol Res Strength, Bandar Sunway 47500, Selangor, Malaysia
[5] Fynn Biotechnol Ltd, Mills Inst Personalized Canc Care, Jinan 250101, Shandong, Peoples R China
来源
ACS CHEMICAL NEUROSCIENCE | 2022年 / 13卷 / 03期
关键词
Sanghuangprous vaninii; extract; Parkinson disease; MPTP; antioxidant; alpha-synuclein; OXIDATIVE STRESS; URSOLIC ACID; ANTIOXIDANT; NEUROTOXICITY; INONOTUS; NEUROINFLAMMATION; POLYSACCHARIDES; POLYPHENOLS; APOPTOSIS; BRAIN;
D O I
10.1021/acschemneuro.1c00656
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Parkinson's disease (PD) is a devastating disease of the central nervous system that occurs mainly in the elderly age group, affecting their quality of life. The PD pathogenesis is not yet fully understood and lacks the disease-modifying treatment strategies. Sanghuangprous vaninii (S. vaninii) is a perennial fungus with a plethora of pharmacological activities including anti-cancer and antioxidant activity and so on. However, no study till date has reported its neuroprotective effect against symptoms that are similar to PD in pre-clinical investigation. In the current study, we investigated anti-PD-like effects of S. vaninii mycelium extracts (SvMEs) on MPTP-induced PD in zebrafish. We observed that the loss of dopaminergic neurons and neurovascular reduction were reversed by using SvMEs in the zebrafish brain in a concentration-independent manner. Moreover, it also relieved locomotor impairments in MPTP-induced PD zebrafish. In addition, SvMEs exerted significant antioxidant activity in vitro, which was also demonstrated in vivo on ktr4:NTR-hKikGR zebrafish. Upon investigating the underlying mechanism, we found that SvMEs may alleviate oxidant stress and accelerate alpha-synuclein degradation and then alleviate PD-like symptoms. Antioxidant-related genes (sod1, gss, gpx4a, gclm, and cat) implied that the SvMEs exhibited anti-PD activity due to the antioxidation mechanism. Finally, upon analysis of chemical composition of SvMEs by liquid chromatography-mass spectrometry, we identified 10 compounds that are plausibly responsible for the anti-PD-like effect of SvMEs. On the limiting part, the finding of the study would have been more robust had we investigated the protein expression of genes related to PD and oxidative stress and compared the effects of SvMEs with any standard anti-PD therapy. Despite this, our results indicated that SvMEs possess anti-PD effects, indicating SvMEs as a potential candidate that is worth exploring further in this avenue.
引用
收藏
页码:330 / 339
页数:10
相关论文
共 50 条
  • [31] Hydroxytyrosol as anti-parkinsonian molecule: Assessment using in-silico and MPTP-induced Parkinson's disease model
    Pathania, Anjana
    Kumar, Rajnish
    Sandhir, Rajat
    BIOMEDICINE & PHARMACOTHERAPY, 2021, 139
  • [32] Neuroprotection effects of probiotics strains on a chronic MPTP-induced mouse model of Parkinson's disease
    Qian, Y.
    Yang, X.
    Xu, S.
    Xiao, Q.
    MOVEMENT DISORDERS, 2018, 33 : S800 - S800
  • [33] Effect of Eleutheroside E on an MPTP-Induced Parkinson's Disease Cell Model and Its Mechanism
    Yao, Yi
    Liao, Caiyu
    Qiu, Honghao
    Liang, Lishan
    Zheng, Wenying
    Wu, Liyan
    Meng, Fanxin
    MOLECULES, 2023, 28 (09):
  • [34] Novel HDAC inhibitors provide neuroprotection in MPTP-induced Parkinson's disease model of rats
    Meka, Sai Teja
    Bojja, Sree Lalitha
    Kumar, Gautam
    Birangal, Sumit Raosaheb
    Rao, Mallikarjuna
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2023, 959
  • [35] Effect of 4-AP on MPP+/MPTP-induced Parkinson's disease model
    Rong, Qiongwen
    Zhou, Chang
    Ma, Yuanyuan
    CELLULAR AND MOLECULAR BIOLOGY, 2023, 69 (08) : 68 - 72
  • [36] MPTP-induced model of Parkinson's disease in heat shock protein 70.1 knockout mice
    Park, Hyun Kyung
    Cho, Ah Rang
    Lee, Seung Chul
    Ban, Ju Yeon
    MOLECULAR MEDICINE REPORTS, 2012, 5 (06) : 1465 - 1468
  • [37] Neuroprotective effect of crocin on substantia nigra in MPTP-induced Parkinson's disease model of mice
    Haeri, Parisa
    Mohammadipour, Abbas
    Heidari, Zahra
    Ebrahimzadeh-bideskan, Alireza
    ANATOMICAL SCIENCE INTERNATIONAL, 2019, 94 (01) : 119 - 127
  • [38] Necrosis inhibitor-5 (NecroX-5), attenuates MPTP-induced motor deficits in a zebrafish model of Parkinson’s disease
    Jun-Cheng Liu
    Sushruta Koppula
    Se-Jong Huh
    Pyo-Jam Park
    Chul-Geun Kim
    Chang-Joong Lee
    Chan-Gil Kim
    Genes & Genomics, 2015, 37 : 1073 - 1079
  • [39] Effects of eugenol on the behavioral and pathological progression in the MPTP-induced Parkinson's disease mouse model
    Vora, Urmi
    Vyas, Vivek Kumar
    Wal, Pranay
    Saxena, Bhagawati
    DRUG DISCOVERIES AND THERAPEUTICS, 2022, 16 (04): : 154 - 163
  • [40] Dysfunction of EAAC1 in MPTP-induced mouse model of Parkinson's disease.
    Aoyama, Koji
    Matsumura, Nobuko
    Watabe, Masahiko
    Nakaki, Toshio
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2007, 103 : 87P - 87P